Latest News

Antidepressant plus addiction medication are elements of new weight-loss drug

A new prescription weight-loss medication that combines a popular antidepressant with a medication for addiction will be reviewed by the Federal Drug Administration (FDA) for potential approval. The new prescription medication is a combination of two FDA-approved drugs, bupropion, an antidepressant and naltrexone, which reduces the desire for drugs and alcohol. Both have been found to increase weight-loss in independent research trials and the partnering of the two in one capsule is believed to create a synergistic effect.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Spastic paraplegia: New light shed on cause

  • Sleep twitches light up the brain

  • Single-neuron 'hub' orchestrates activity of an entire brain circuit

  • 'Frenemy' in Parkinson's disease takes to crowdsourcing

  • Self-compassion key to positive body image, coping

  • Brief depression questionnaires could lead to unnecessary antidepressant prescriptions

  • CHICA system improves developmental delay screening, surveillance

  • The dangers of teens using marijuana

  • Jersey drivers admit to risky behaviors, poll finds

  • Talk therapy -- not medication -- best for social anxiety disorder, large study finds

  •